GPC3 protein expression was observed in >30% of samples from patients with HCC, squamous cell carcinoma of the lung (SCC), Merkel cell carcinoma (MCC), and liposarcoma demonstrating its attractiveness as a CAR tumor antigen target. This evidence concerns the gene GPC3 and liposarcoma.